Improving drug safety surveillance: lessons from rosiglitazone.
Masoudi
Frederick A
FA
D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000191:economics / Q000453:epidemiology* / Q000401:mortality; D006801:Humans; D008329:Managed Care Programs; D009203:Myocardial Infarction / Q000191:economics / Q000453:epidemiology* / Q000401:mortality; D011785:Quality Assurance, Health Care; D012306:Risk; D000077154:Rosiglitazone; D016019:Survival Analysis; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States
D045162:Thiazolidinediones; D000077154:Rosiglitazone